Trial Profile
The Role of DLBS1033 in the Management of Acute Ischemic Stroke Patients: A Randomized Controlled Study
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Lumbricus rubellus (Primary) ; Citicoline; Simvastatin; Vitamin B complex
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Dexa Medica
- 12 Feb 2017 Planned End Date changed from 1 Jul 2017 to 1 Apr 2017.
- 12 Feb 2017 Status changed from recruiting to discontinued.
- 03 Aug 2016 Planned number of patients changed from 116 to 104.